section name header

Indications

BEERS REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: HF, MI, STROKE, edema, hypertension, palpitations.

Derm: DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), EXFOLIATIVE DERMATITIS, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, ecchymoses, flushing, hyperpigmentation, pruritus, rash, sweating.

EENT: blurred vision, photophobia, tinnitus.

GI: GI BLEEDING, dyspepsia, abdominal pain, constipation, diarrhea, drug-induced hepatitis, dry mouth, flatulence, gastritis, nausea, stomatitis, thirst, vomiting.

GU: dysuria, renal failure, urinary frequency.

Hemat: anemia, prolonged bleeding time, thrombocytopenia.

Neuro: depression, dizziness, drowsiness, insomnia, malaise, nervousness, syncope, weakness.

Resp: asthma.

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS AND ANGIOEDEMA), chills, fever.

Interactions

Drug-Drug:

Drug-Natural Products:

Availability

(Generic available)

Route/Dosage

US Brand Names

Lodine, Lodine XL

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antirheumatics, nonopioid analgesics

Pharmacologic Classification:

Pharmacokinetics

Absorption: Well absorbed after oral administration.

Distribution: Widely distributed.

Protein Binding: >99%.

Metabolism/Excretion: Mostly metabolized by the liver; <1% excreted unchanged in urine.

Half-life: 6–7 hr (single dose); 7.3 hr (chronic dosing).

Time/Action Profile

(analgesic effect)

ROUTEONSETPEAKDURATION
PO (analgesic)0.5 hr1–2 hr4–12 hr
PO (anti-inflammatory)days–wkunknown6–12 hr

†Up to 24 hr as XL (extended-release) tablet.

Patient/Family Teaching

Pronunciation

ee-TOE-doe-lak

Code

NDC Code*